"Big Four" Pharmaceutical Pricing Boot Camp

Intensive training in the essential pricing concepts and methodologies related to VA, DoD, PHS, and Coast Guard programs

Monday, May 21, 2007

About

Learn to work effectively and efficiently with the largest purchaser of pharmaceutical products

The U.S. government spends billions of dollars per year on the purchase of drugs, making it the largest purchaser of pharmaceuticals in the U.S. Sales to the government typically account for a large portion of a company’s total revenue, and a company cannot remain competitive in today’s market without selling to the government. As pharmaceutical manufacturers’ revenue and profits are so closely tied to government contracts and pricing, it is essential to have a thorough understanding of the Veterans Health Care Act, Federal Supply Schedule Contracting, Federal Ceiling Price, and pharmacy benefits programs.

While having the government as a client is lucrative, it can be costly, time consuming and confusing. Understanding the basics and key terms of “Big Four” pricing is necessary to ensure that companies do not enter into price contracts that obligate them to comply with impossible terms. Selling to the VA, DoD, PHS and Coast Guard also requires constant price calculations and price reporting. These calculations are often perplexing and result in price anomalies that can leave even the most seasoned contracting practitioner baffled. On top of complying with the “Big Four’s” numerous rules and regulations, companies must also evaluate how their “Big Four” prices affect their overall pricing.

Master the essentials of key “Big Four” pricing concepts and methodologies

This publication from ACI’s “Big Four” Pharmaceutical Pricing Boot Camp has been designed to give novices and experienced practitioners alike a complete understanding of core pricing competencies. ACI has assembled a faculty of the government authorities on “Big Four” pricing and pharmacy benefits programs along with expert pricing practitioners. This distinguished faculty will make sense of complicated terminology and pricing calculations and teach you how to navigate the complexities of working with the “Big Four” agencies.

Contents & Contributors

About

Learn to work effectively and efficiently with the largest purchaser of pharmaceutical products

The U.S. government spends billions of dollars per year on the purchase of drugs, making it the largest purchaser of pharmaceuticals in the U.S. Sales to the government typically account for a large portion of a company’s total revenue, and a company cannot remain competitive in today’s market without selling to the government. As pharmaceutical manufacturers’ revenue and profits are so closely tied to government contracts and pricing, it is essential to have a thorough understanding of the Veterans Health Care Act, Federal Supply Schedule Contracting, Federal Ceiling Price, and pharmacy benefits programs.

While having the government as a client is lucrative, it can be costly, time consuming and confusing. Understanding the basics and key terms of “Big Four” pricing is necessary to ensure that companies do not enter into price contracts that obligate them to comply with impossible terms. Selling to the VA, DoD, PHS and Coast Guard also requires constant price calculations and price reporting. These calculations are often perplexing and result in price anomalies that can leave even the most seasoned contracting practitioner baffled. On top of complying with the “Big Four’s” numerous rules and regulations, companies must also evaluate how their “Big Four” prices affect their overall pricing.

Master the essentials of key “Big Four” pricing concepts and methodologies

This publication from ACI’s “Big Four” Pharmaceutical Pricing Boot Camp has been designed to give novices and experienced practitioners alike a complete understanding of core pricing competencies. ACI has assembled a faculty of the government authorities on “Big Four” pricing and pharmacy benefits programs along with expert pricing practitioners. This distinguished faculty will make sense of complicated terminology and pricing calculations and teach you how to navigate the complexities of working with the “Big Four” agencies.

Contents & Contributors

KNOWING YOUR CUSTOMER: OVERVIEW OF THE “BIG FOUR” AND THEIR PHARMACEUTICAL RELATED PROGRAMS
David C. Hammond, Crowell & Moring LLP

ESTABLISHING THE FEDERAL CEILING PRICE (FCP)
Joy E. Sturm, Hogan & Hartson LLP Marci Anderson, VA Office of Inspector General
Melbourne A. Noel, Jr., Department of Veteran Affairs
John D. Shakow, King & Spalding

FSS CONTRACTING FOR THE PHARMACEUTICAL INDUSTRY
Melbourne A. Noel, Jr., Department of Veteran Affairs

EFFECTIVELY MANAGING NEGOTIATIONS WITH V.A.
William W. Goodrich, Jr., Arent Fox LLP

DISCLOSURES AND NEGOTIATIONS: WHAT VA EXPECTS
Maureen Regan, VA Office of Inspector General

PRICE ADJUSTMENT CLAUSE AND PRICE REDUCTION CLAUSE
Stephen E. Ruscus, McKenna Long & Aldridge

PRICE ADJUSTMENT AND PRICE REDUCTION CLAUSES: VA’S PERSPECTIVE
Maureen Regan, VA Office of Inspector General

VA PHARMACY BENEFITS MANAGEMENT STRATEGIC HEALTHCARE GROUP UPDATE
Joseph J. Canzolino, R.PH. , Pharmacy Benefits Managements Strategic Healthcare Group

DEMYSTIFYING THE DOD UNIFORM FORMULARY
Allison D. Pugsley, Esq., Hogan & Hartson LLP

STRATEGIES FOR SECURING NATIONAL CONTRACTS
David C. Hammond, Crowell & Moring LLP

TRICARE: A STUDY IN THE DOD’S MANAGED HEALTH CARE BENEFITS PROGRAM
Joy E. Sturm, Hogan & Hartson LLP
Melbourne A. Noel, Jr., Department of Veteran Affairs
Howard R. Altschwager, TRICARE Management Activity

BASICS OF PHS 340B DRUG DISCOUNT PROGRAM
Edward J. McAdam, Sr., Daiichi Sankyo, Inc.
William von Oehsen, Powers Pyles Sutter & Vervile PC

OVERVIEW OF THE DEPARTMENT OF DEFENSE (DOD) PHARMACY PROGRAM
Howard R. Altschwager, TRICARE Management Activity

TRICARE RETAIL PHARMACY PROGRAM: EVOLUTION OF THE RETAIL REBATE
Joy E. Sturm, Hogan & Hartson LLP

PROPOSED RULE PUBLISHED FOR PUBLIC COMMENT IN 70 FEDERAL REGISTER, PAGE 19045, APRIL 12, 2005
Melbourne A. Noel, Jr., Department of Veteran Affairs

AUDIT RIGHTS, RECORD RETENTION AND PENALTIES
William W. Goodrich, Arent Fox LLP

AUDIT RIGHTS, RECORD RETNETION AND PENALTIES
Maureen Regan, VA Office of Inspector General

ENFORCEMENT LANDSCAPE IN PHARMACEUTICAL GOVERNMENT CONTRACTING
Elizabeth I. Hack, McDermott Will & Emery

THE MEDICAID/340B PROGRAM “BEST PRICE” ENFORCEMENT LANDSCAPE
Kirsten Mayer, Ropes & Gray LLP



DOCUMENT TYPES: PRESENTATIONS AVAILABLE: 0